Surveys for parents and staff working in schools and ECEC
The National Allergy Strategy is developing minimum standards for the prevention and management of anaphylaxis (severe allergic reactions) in schools and childcare.
To help us to develop these standards, we would like parents/guardians who have a child with severe allergies enrolled in a school and/or childcare service and staff who work in school or childcare, to complete a national online survey about how severe allergies should be managed in these settings.
The survey will take approximately 15 minutes to complete and all information collected will be anonymous – we will not be able to identify you or the name of the school and/or childcare service where your child attends.
Please take the time to complete the survey and help guide the development of the minimum standards. Please also share this information with friends and colleagues.
The surveys can be accessed from the National Allergy Strategy website
The surveys close at midnight on Friday 25 September 2020.
Read more: Management of anaphylaxis in schools and early childhood education and care (ECEC) - surveys
Read more: Webinar recording and slides now available: An overview of My Health Record for Clinical...
15 June 2020:
The National Allergy Strategy welcomes the Walking the allergy tightrope report tabled today by Trent Zimmerman, chair of the committee which conducted a parliamentary inquiry into allergies and anaphylaxis. The National Allergy Strategy also acknowledges the support provided by the Hon Greg Hunt, Minister for Health in progressing the inquiry.
Walking the allergy tightrope - Addressing the rise of allergies and anaphylaxis in Australia1.15 MB
“We would like to thank the parliamentary inquiry committee for what has been a very thorough and considered inquiry into the impact of allergic diseases,” said Dr Preeti Joshi, Co-chair of the National Allergy Strategy. “It was clear from the way the hearings were conducted that this Committee wanted to identify and understand all the important issues,” Dr Joshi said.
The National Allergy Strategy specifically welcomes recommendations regarding the establishment of an anaphylaxis register, additional allergy research, consideration of a healthcare card for allergic consumers, national standardisation of emergency department discharge after anaphylaxis admissions, minimum standards for allergy training for health professionals, improved training for food service, improved access to food and drug challenges, and improvement and expediating of food labelling.
It is also encouraging that the Committee recognises the importance of the National Allergy Strategy, Allergy & Anaphylaxis Australia (A&AA) and Australasian Society of Clinical Immunology and Allergy (ASCIA), as key organisations providing expertise and support to the community. We hope that ongoing sufficient funding will continue to support the important work each organisation undertakes.
“The National Allergy Strategy, is a partnership between the Australasian Society of Clinical Immunology and Allergy (ASCIA) and Allergy & Anaphylaxis Australia, the peak medical and patient support organisations for Australia and this is a key strength of the Strategy,” Ms Said, Co-chair of the National Allergy Strategy stated. “We are able to put consumers at the centre of everything we do with the support of the peak medical body and other key stakeholder organisations,” she said.
In 2015, the National Allergy Strategy was launched with the support of key stakeholder organisations who worked together to develop a blueprint for what needed improving and how it could be achieved. The recommendations tabled today address many of the key issues that the National Allergy Strategy believes are important to improving the management of allergic diseases in Australia.
Read more: National Allergy Strategy welcomes report from parliamentary inquiry into allergies and anaphylaxis
25 March 2020:
Healthdirect Australia have asked the National Allergy Strategy to share the COVID‑19 Symptom Checker they have developed for people that are unwell and think they may have COVID‑19.
As medical staff, testing clinics and the National Coronavirus Helpline are overwhelmed with enquiries, the symptom checker can help alleviate pressure.
The COVID‑19 Symptom Checker provides people with advice on whether medical help is required and what they should do next, such as calling ahead before a visit to a GP or emergency department.
Access to the COVID‑19 Symptom Checker is available from the National Allergy Strategy website: www.nationalallergystrategy.org.au
Read more: New COVID-19 Symptom Checker
Read more: Information about COVID-19
5 March 2020:
The Australasian Society of Clinical Immunology and Allergy (ASCIA) through the National Allergy Strategy is collaborating with the Australian Digital Health Agency to provide information to clinical immunology/allergy specialists about using My Health Record to improve patient care.
This new Fact sheet for clinical immunology/allergy specialists developed by the National Allergy Strategy includes information about:
- what’s in it for you and your patients;
- benefits for clinical immunology/allergy specialists; and
- safety and security of patient information.
MHR Fact Sheet for Clinical Immunology/Allergy specialists208.13 KB
Additional resources designed to support your use of My Health Record in clinical practice are being developed as part of this project and will be released once complete.
Read more: Using My Health Record: Fact sheet for clinical immunology/allergy specialists
26 February 2020:
Understanding how to register and upload to My Health Record can be challenging. Join Professor Steven Boyages as he interviews Carey Doolan from the Australian Digital Health Agency to provide practical advice to help you register and upload to My Health Record. To register for this webinar on 4th March 2020, 6-7pm AEDT go to here.
For information about how the National Allergy Strategy is working with the Australian Digital Health Agency to improve the quality of patient allergy information in My Health Record go to NAS - Digital Health Agency
Read more: Register for the My Health Record Webinar – Wednesday 4 March 6pm -7pm AEDT
19 November 2019:
The National Allergy Strategy was pleased to be invited to speak at the public hearing of the parliamentary inquiry into allergy and anaphylaxis, in Sydney on the 19th November 2019. ASCIA and Allergy & Anaphylaxis Australia were also invited to speak at the hearing.
We would once again, like to acknowledge Mr Trent Zimmerman and Minister Hunt for their support of Australians living with allergic diseases by conducting this inquiry.
Pictured from: left Dr Preeti Joshi, Ms Karen Wong (back) Ms Maria Said, Mr Trent Zimmerman, Dr Mike Freelander, Ms Sandra Vale, Dr Brynn Wainstein, Ms Jody Aiken and Ms Jill Smith
Read more: Parliamentary inquiry into allergy and anaphylaxis